The information on this site is intended for consumers and healthcare professionals in the European Economic Area or the United Kingdom. Eroxon is not available in jurisdictions outside the European Economic Area or the United Kingdom. Users outside these jurisdictions,
please click here.
This accessibility statement applies to www.eroxon.com
This website is run by Futura Medical Group. We want as many people as possible to be able to use this website. For example, that means you should be able to:
AbilityNet has advice on making your device easier to use if you have a disability.
This includes how to:
You can translate this website to your preferred language by changing the settings in your browser (such as Internet Explorer, Chrome or Safari).
We aim to meet World Wide Web Consortium (W3C) Web Content Accessibility Guidelines 2.1 AA guidelines. We have listed areas of the site that we know are not fully accessible:
If you need information on this website in a different format like accessible PDF, large print, easy read, audio recording or braille, please email eroxon@futuramedical.com We will consider your request and get back to you within five working days.
Visit our Contact Us page to find further ways of getting in touch.
We are always looking to improve the accessibility of this website. If you find any problems not listed on this page or think we’re not meeting accessibility requirements, please email eroxon@futuramedical.com to let us know.
The Equality and Human Rights Commission (EHRC) is responsible for enforcing the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018 (the ‘accessibility regulations’). If you are not happy with how we respond to your complaint, contact the Equality Advisory and Support Service (EASS).
Futura Medical Group is committed to making its website accessible, in accordance with the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018.
This website is partially compliant with the Web Content Accessibility Guidelines version 2.1, due to the non-compliances listed below.
The content listed below is non-accessible for the following reasons:
Non-compliance with the accessibility regulations
We are working with our supplier to address the above mentioned issues.
This statement was prepared on 29 March 2023. It was last reviewed on 31 March 2023.